Pyramid Healthcare, Inc.

Pyramid Healthcare, Inc. is a provider of comprehensive behavioral health care services specializing in addiction treatment for adults and adolescents. They focus on tailored care to support recovery from substance abuse and addiction. Pyramid Healthcare, Inc.

was founded in 1999 in the United States and specializes in addiction treatment services. The company operates various facilities across several states, including Maryland, Massachusetts, New Jersey, North Carolina, Pennsylvania, Virginia, and West Virginia. The firm has completed three deals, with the most recent deal occurring on May 10, 2021, when Clearview Capital exited its stake in the company. The founder's specific history and prior ventures are not disclosed.

Pyramid Healthcare specializes in providing a comprehensive continuum of behavioral health care services aimed at adults and adolescents grappling with substance abuse and addiction. Their core offerings include detoxification services, residential treatment programs, partial hospitalization, intensive outpatient programs, and outpatient treatment. These services address various stages of addiction recovery, ensuring clients receive the appropriate level of care tailored to their individual needs. The company's mission is to assist individuals and families in overcoming addiction, fostering long-term recovery and improved health outcomes through its well-trained staff and structured treatment plans.

Pyramid Healthcare generates revenue primarily through direct service fees associated with its addiction treatment programs, including detoxification, residential treatment, and outpatient services. Clients typically engage with the company through assessments and admissions, often utilizing insurance plans such as Medicaid and other commercial insurers to cover treatment costs. Revenue is supported by partnerships with various insurance providers, promoting accessibility to necessary care while ensuring sustainable operations. Pyramid Healthcare is focused on expanding its service offerings and geographical reach.

There are plans to introduce new products and services aimed at enhancing treatment options, with specific release dates yet to be announced. Additionally, the company is targeting expansion into new markets, including potential new locations in neighboring states by the end of 2023. The funds from the most recent deal on May 10, 2021, will be utilized to support these expansion initiatives and enhance service delivery to meet growing demands in addiction treatment.